Last scanned
Domain Age
Daily Visitors
Global Rank
Updated:
Fabrazyme® (agalsidase beta) | ERT for Fabry Disease
Fabrazyme is an enzyme replacement therapy (ERT) used to treat patients with Fabry disease for over 17 years. See how it works, get copay assistance for qualified patients and more.
This website is hosted with Amazon.com, Inc., which reserves the following IP addresses for fabrazyme.com: 18.67.65.18, 18.67.65.34, 18.67.65.52, 18.67.65.89. Moreover, DNS used with this website include ns1.sanofi-synthelabo.com, ns2.sanofi-synthelabo.com, ns3.sanofi-synthelabo.com, ns4.sanofi-synthelabo.com. Subnet identifier ranges from 18.64.0.0 to 18.67.255.255. Classless Inter-Domain Routing (CIDR) is 18.64.0.0/14. ARIN net type is Reallocated.
Last scanned
Domain Age
Daily Visitors
Global Rank
ns1.sanofi-synthelabo.com
ns2.sanofi-synthelabo.com
ns3.sanofi-synthelabo.com
ns4.sanofi-synthelabo.com
{{value}}
1999-12-06
2024-12-06
CSC CORPORATE DOMAINS, INC.
{{value}}
The registrar of fabrazyme.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2024-12-06. According to open source data, you can reach the owner at domain.names@sanofi.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.
N/A
267
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A